Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...
Zydus Lifesciences has received permission to conduct a Phase III clinical trial of Desidustat for patients with sickle cell disease. Conducted in collaboration with the Indian Council of Medical ...
healthdigest.com on MSN
The surprising connection between anemia and your weight
Anemia is a condition where you don't have enough healthy red blood cells to carry oxygen to your body. But what effect can ...
The contract is to be executed by PTC industries over a period of 2.5 years. The financial value of the order has not been ...
The Rajasthan Board of Secondary Education, RBSE has officially released the syllabus for Class 12 Biology Compulsory for the upcoming 2026-2027 academic session. This revised curriculum is now ...
Agios drops after ending tebapivat development for SCD as phase II data confirmed PK activation but failed to show sufficient clinical differentiation.
On Thursday, 1,637 stocks advanced, 2,585 declined, and remained unchanged on the Bombay Stock Exchange with an advance-decline ratio of 0.63, indicating a negative closing.
Sickle cell disease is the most common genetic blood disorder in the U.S. and primarily affects the Black community.
Family planning begins with conversations about nutrition, vaccinations and lifestyle. Yet there is another important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results